Keywords: fda, oks, ixempra, breast, cancer, drug, major

FDA OKs Ixempra for breast cancer

Article | 22 October 2007

Print This

US drug major Bristol-Myers Squibb says that the US Food and Drug Administration has approved its drug Ixempra (ixabepilone) as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in